ScholarLens Back to search
2008•Hainan yixueRequires access

Clinical efficacy of edaravone on acute stage of cerebral hemorrhage

Peifeng Liu

Open publisher page 0 citations

Abstract

Objective To discuss the efficacy of edaravone on the treatment of acute cerebral hemorrhage(CH). Methods 120 acute CH cases were divided into treatment group(n=60) and control group(n=60) randomly. Edaravone was given to the treatment group at a dose of 30 mg, twice a day, for 14 days. Meanwhile, the basic treatment were taken. Results the total clinic valid rate of the treatment group was 83.3%, the control group was 63.3%. There were significan difference between the treatment group and control group (P0.05), the treatment group was better than the control group obviously. Conclusions Edaravone has a obvious effect on the acute stage of cerebral hemorrhage.

About this research paper

What this paper is about

Objective To discuss the efficacy of edaravone on the treatment of acute cerebral hemorrhage(CH). Methods 120 acute CH cases were divided into treatment group(n=60) and control group(n=60) randomly. Edaravone was given to the treatment group at a dose of 30 mg, twice a day, for 14 days. Meanwhile, the basic treatment were taken. Results the total clinic valid rate of the treatment group was 83.3%, the control group was 63.3%. There were significan difference between the treatment group and control group (P0.05), the treatment group was better than the control group obviously. Conclusions Edaravone has a obvious effect on the acute stage of cerebral hemorrhage.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To discuss the efficacy of edaravone on the treatment of acute cerebral hemorrhage(CH). Methods 120 acute CH cases were divided into treatment group(n=60) and control group(n=60) randomly. Edaravone was given to the treatment group at a dose of 30 mg, twice a day, for 14 days. Meanwhile, the basic treatment were taken. Results the total clinic valid rate of the treatment group was 83.3%, the control group was 63.3%. There were significan difference between the treatment group and control group (P0.05), the treatment group was better than the control group obviously. Conclusions Edaravone has a obvious effect on the acute stage of cerebral hemorrhage.

Key concepts: Edaravone, Medicine, Clinical efficacy, Anesthesia, Treatment and control groups, Stage (stratigraphy), Significant difference, Conventional treatment

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical efficacy of edaravone on acute stage of cerebral hemorrhage — Research Paper | ScholarLens